BG Medicine Announces Obtaining CE Mark and Launching of Automated BGM Galectin-3 Test
[at noodls] – WALTHAM, Mass., Jan. 2, 2013 (GLOBE NEWSWIRE) — BG Medicine, Inc. (Nasdaq:BGMD), a company focused on the development and commercialization of novel cardiovascular diagnostics, announced today that the … moreView todays social media effects on BGMDView the latest stocks trending across Twitter. Click to view dashboardSee who BG is hiring next, click here to view […]